Erratum: Duplex doppler ultrasound examination of the portal venous system: An emerging novel technique for the estimation of portal vein pressure (Digestive Diseases and Sciences DOI: 10.1007/s10620-009-0887-0);Duplex doppler ultrasound examination of the portal venous system: An emerging novel technique for the estimation of portal vein pressure

Digestive Diseases and Sciences

Volumn 55, Issue 5, 2010, Pages 1230-1240

  Singal, Ashwani K ^a   Ahmad, Masood ^a   Soloway, Roger D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Beta blockers; Doppler ultrasound; Duplex ultrasound; Portal hypertension; Portal pressure; Variceal hemorrhage

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ARTERIAL PRESSURE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DISEASE MARKER; DOPPLER ECHOGRAPHY; DRUG EFFICACY; HEPATIC VEIN CATHETERIZATION; HEPATIC VENOUS PRESSURE GRADIENT; HUMAN; PARACENTESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SUPERIOR MESENTERIC ARTERY; VASCULAR PATENCY; VEIN CATHETERIZATION; VENOUS PRESSURE; CATHETERIZATION; ECHOGRAPHY; HEMODYNAMICS; PATHOPHYSIOLOGY; PORTAL VEIN;

CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; PORTAL SYSTEM; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 77953640133     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1216-3     Document Type: Erratum

References (63)

1. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am. 1992;21:1-14.
2. Langer DA, Shah VH. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis. J Hepatol. 2006;44:209-216.
3. D' Amico G, Garcia-Tsao G. Diagnosis of portal hypertension: how and when. In: deFranchis R, ed. Portal hypertension. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies. Oxford (UK): Blackwell Science; 2001:36-64.
4. Braillon A, Cales P, Valla D, et al. Influence of the degree of liver failure on splanchnic hemodynamics and response to proparanol in patients with cirrhosis. Gut. 1986;27:1204-1209.
5. Picchiotti R, Mingazzini P, Scucchi L, et al. Correlation between sinusoidal pressure and liver morphology in cirrhosis. J Hepatol. 1994;20:364-369.
6. Gluud C, Henriksen J, Nielsen G. Prognositic indicators in alcoholic cirrhosis men. Hepatology. 1988;8:222-227.
7. Merkel C, Bolognesi M, Bellon S, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992;102:973-979.
8. Viallet A, Marleau D, Huet M, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension: relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297-1300.
9. Rigau J, Bosch J, Bordas JM, et al. Endoscopic measurement of portal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96:873-880.
10. Blei AT. Portal hypertension and its complications. Curr Opin Gastroenterol. 2007;23:275-282.
11. Grosszman RJ, Bosch J, Grace N, et al. Hemodynamic events in a prospective randomized trial of proparanolol versus placebo in the prevention of first variceal hemorrhage. Gastroenterology. 1990;99:1401-1407.
12. Feu F, García-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet. 1995;346:1056-1059.
13. Pomier-Layrarques G, Kusielewicz D, Willems B, et al. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985;5:415-418.
14. Myers JD, Taylor WJ. Occlusive hepatic venous catheterization in the study of the normal liver, cirrhosis of the liver and noncirrhotic portal hypertension. Circulation. 1956;13:368-380.
15. Grosszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280-282.
16. Wongcharatrawee S, Groszmann RJ. Diagnosing portal hypertension. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:881-894.
17. Perello A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393-1397.
18. Grosszmann RJ, Glickman M, Blei AT, et al. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology. 1979;76:253-258.
19. Parikh S. Hepatic venous pressure gradient: worth another look? Dig Dis Sci. 2009;54:1178-1183.
20. Steinlauf AF, Garcia-Tsao G, Zakko MF, Dickey K, Gupta T, Grosszmann RJ. Low dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology. 1999;29:1070-1073.
21. Miller VE, Berland LL. Pulsed Doppler duplex sonography and CT of portal vein thrombosis. Am J Roentgenol. 1985;145:73-76.
22. Sabba C, Merkel C, Zoli M, et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology. 1995;21:428-433.
23. Zulke C, Matejovic M, Trager K, Radermacher P. Validation of portal vein flow measurement by color flow Doppler sonography in a porcine model of septic shock. Intensive Care Med. 2005;31:1288-1291.
24. Chow PK, Yu WK, Ng TH, et al. Influence of Doppler and portal pressure on transabdominal duplex Doppler ultrasound measurement of portal blood flow: a porcine model for experimental studies. J Surg Res. 2000;89:66-73.
25. Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol. 1991;157:293-296.
26. Hosoki T, Arisawa J, Marukawa T, et al. Portal blood flow in congestive heart failure: pulsed duplex sonographic findings. Radiology. 1990;174:733-736.
27. Baik SK, Kim JW, Kim HS, et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology. 2006;240:574-580.
28. Kim MY, Baik SK, Park DH, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int. 2007;27:1103-1110.
29. Nelson RC, Lovett KE, Chezmar JL, et al. Comparison of pulsed Doppler sonography and angiography in patients with portal hypertension. AJR Am J Roentgenol. 1987;149:77-81.
30. Gaiani S, Bolondi L, Li Bassi S, Santi V, Zironi G, Barbara L. Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology. 1989;9:815-819.
31. Subramanyam BR, Balthazar EJ, Madamba MR, Raghavendra BN, Horii SC, Lefleur RS. Sonography of portosystemic venous collaterals in portal hypertension. Radiology. 1983;146:161-166.
32. Gibson RN, Gibson PR, Donlan JD, Clunie DA. Identification of a patent paraumbilical vein by using Doppler sonography: importance in the diagnosis of portal hypertension. AJR Am J Roentgenol. 1989;153:513-516.
33. Zoli M, Iervese T, Merkel C, et al. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol. 1993;17:56-61.
34. Moriyasu F, Nishida O, Ban N, et al. "Congestion index" of the portal vein. AJR Am J Roentgenol. 1986;146:735-739.
35. Fernandez-Munoz D, Caramelo C, Santos JC, Blanchart A, Hernando L, Lopez-Novoa JM. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol. 1985;249:G316-G320.
36. Iwao Y, Kim YI, Kaketani K, Nakashima K, Okada K, Kobayashi M. Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma. Hepatogastroenterology. 1993;40:491-495.
37. Dodd GDIII, Memel DS, Zajko AB, Baron RL, Santaguida LA. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology. 1994;192:657-661.
38. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Enzo E, Gatta A. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol. 1997;26:305-311.
39. Berzigotti A, Casadei A, Magalotti D, et al. Renovascular impedance correlates with portal pressure in patients with liver cirrhosis. Radiology. 2006;240:581-586.
40. Tasu JP, Rocher L, PEletier G, et al. Hepatic venous pressure gradients measured by duplex ultrasound. Clin Radiol. 2002;57:746-752.
41. Samonakis DN, Triantos CK, Thalheimer U, et al. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl. 2005;11:386-395.
42. Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 1992;16:298-303.
43. Zhang L, Duan YY, Li JM, Yin JK. Hemodynamic features of Doppler ultrasonography in patients with portal hypertension: intraoperative direct measurement of portal pressure in the portal venous system. J Ultrasound Med. 2007;26:1689-1696.
44. Vizzutti F, Arena U, Rega L, et al. Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease. Liver Int. 2007;27:1379-1388.
45. Choi YJ, Baik SK, Park DH, et al. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol. 2003;18:424-429.
46. Jeong PH, Baik SK, Choi YJ, et al. Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. Taehan Kan Hakhoe Chi. 2002;8:264-270.
47. Taourel P, Blanc P, Dauzat M, et al. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology. 1998;28:932-936.
48. Merkel C, Sacerdoti D, Bolognesi M, Bombonato G, Gatta A. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol. 1998;28:622-630.
49. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler. Ultrasound Med Biol. 2001;27:901-907.
50. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332-354.
51. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology. 2000;31:1239-1245.
52. Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32:461-465.
53. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361:952-954.
54. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611-1624.
55. Abraczinskas DR, Ookubo R, Grace ND, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology. 2001;34:1096-1102.
56. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009.
57. Asselah T, Bieche I, Sabbagh A, Bedossa P, Moreau R, Valla D, Vidaud M, et al. Gene expression and hepatitis C virus infection. Gut. 2009;58:846-858.
58. Schepke M, Raab P, Hoppe A, Schiedermaier P, Brensing KA, Sauerbruch T. Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol. 2000;95:2905-2909.
59. Castano G, Viudez P, Carlevaro O, et al. Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis. Acta Gastroenterol Latinoam. 1998;28:291-297.
60. Luca A, Garcia-Pagan JC, Feu F, et al. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. Hepatology. 1995;21:83-88.
61. Cioni G, Turrini F, Tincani E, et al. Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. J Ultrasound Med. 1999;18:633-638.
62. Berzigotti A, Rinaldi MF, Magalotti D, et al. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. J Hepatol. 2006;44:310-316.
63. Merkel C, Sacerdoti D, Bolognesi M, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology. 1997;26:34-39.